Centering Patient Voices in Real-World Evidence: New MDIC Guidance Opens the Door and BISA Highlights the Path Forward
The MDIC released new guidance on using real-world data. As momentum builds around direct patient input, BISA offers practical recommendations to turn this progress into lasting safety, trust, and meaningful partnerships.
BISA’s Recap of the FDA PEAC Meeting on Patient-Centered Informed Consent
It was encouraging to see the FDA gather expert opinions along with patient advocates and advisors to create improved guidance on more patient-centered informed consent materials for potential participants considering involvement in a clinical study. BISA compiled a few takeaways after the meeting.